The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database
- Supplementary File 1:
ZIP-Document (ZIP, 1709 KiB)
Kim, G.L.; Yi, Y.H.; Hwang, H.R.; Kim, J.; Park, Y.; Kim, Y.J.; Lee, J.G.; Tak, Y.J.; Lee, S.H.; Lee, S.Y.; Cho, Y.H.; Park, E.J.; Lee, Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. J. Clin. Med. 2021, 10, 2044. https://doi.org/10.3390/jcm10092044
Kim GL, Yi YH, Hwang HR, Kim J, Park Y, Kim YJ, Lee JG, Tak YJ, Lee SH, Lee SY, Cho YH, Park EJ, Lee Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. Journal of Clinical Medicine. 2021; 10(9):2044. https://doi.org/10.3390/jcm10092044
Chicago/Turabian StyleKim, Gyu L., Yu H. Yi, Hye R. Hwang, Jinmi Kim, Youngmin Park, Yun J. Kim, Jeong G. Lee, Young J. Tak, Seung H. Lee, Sang Y. Lee, Youn H. Cho, Eun J. Park, and Youngin Lee. 2021. "The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database" Journal of Clinical Medicine 10, no. 9: 2044. https://doi.org/10.3390/jcm10092044